drugset / Trial / NCT02388347

A Study to Assess the Safety of MEDI7836 in Healthy Adults.

NCT02388347 ↗

Phase 1 Completed 79 enrolled MedImmune LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the safety of a single ascending dose of MEDI7836 in healthy adult male subjects and healthy adult female subjects of non-childbearing potential.

Timeline

Start
2015-03
Primary completion
2016-01
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject MEDI7836 Unknown — Subcutaneous

Indications

No indication recorded.